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ABSTRACT  
 
Aim: Acute abdominal pain is a frequent complaint in children attending emergency 
departments. The aim of this study was to investigate the pain score reductions when children 
with acute abdominal pain received medication sublingually.  
Methods: We carried out a multicentre randomised controlled trial in three children’s hospitals 
in Italy between March 2015 and June 2017. Children from four to 18 years of age with acute 
abdominal pain were recruited if their self-reported pain was at least six on a scale from 0-10.  
The children were randomised to receive ketorolac 0.5mg/kg (n=70) or tramadol 2mg/kg 
(n=70) sublingually or a melt in the mouth powder of 20mg/kg paracetamol (n=70). The main 
study outcome was the pain scores for the three drugs after two hours.   
Results: The 210 children (58.6% girls) had a median age of 12 years with an interquartile 
range of  9-14.3. The median pain scores at two hours were not significantly different between 
ketorolac 2.0 (IQR 0.0-4.3) and tramadol 3.0 (IQR 1.0-5.0) versus paracetamol 3.0 (IQR 0.8-5.0). 
The median pain reductions were all 5.0 points. 
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Conclusions: Delivering analgesia sublingually was a suitable option for pain relief in children 
with acute abdominal pain in the emergency department. 
 
Keywords: analgesia, acute abdominal pain, children, emergency department, sublingual  
 
Abbreviations: interquartile ranges (IQR), non-steroidal anti-inflammatory drug (NSAID),  
relative risk (RR) 
 
Key notes 
 This study compared the pain score reductions when children with acute abdominal 
pain receive medication sublingually in the emergency department.  
 The children were randomised to receive ketorolac 0.5mg/kg (n=70) or tramadol 
2mg/kg (n=70) sublingually or a melt in the mouth powder of 20mg/kg paracetamol 
(n=70).  
 After two hours the median pain scores had all reduced by five points, demonstrating 
that delivering medication sublingually was a feasible option.  
 
INTRODUCTION 
Acute abdominal pain accounts for approximately 9% of childhood visits to primary care and it 
is a frequent complaint in emergency departments, with a large number of resources spent on 
its evaluation and management (1,2).  
The American Academy of Pediatrics recommends early analgesia in children with acute 
abdominal pain, to make the physical examination and diagnostic testing more comfortable (3). 
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The available evidence supports the use of intravenous opioids for analgesia in children with 
acute abdominal pain and randomised controlled studies have demonstrated that early 
analgesia does not influence the clinical examination and does not obscure the diagnosis of 
surgical conditions (4,5). The intravenous route of administration is not the only way to provide 
early analgesia in paediatric patients with acute pain, as several studies have showed that 
transmucosal analgesia is effective in this population (6-8). 
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) and tramadol is a synthetic opioid 
analogue of codeine. Both drugs are effective when administered under the tongue (7) and they 
could be satisfactorily used in children with acute pain (9,10). To the best of our knowledge, no 
randomised controlled studies have investigated the effect of ketorolac and tramadol for pain 
relief in children with acute abdominal pain.  
Therefore, the aim of this study was to investigate the pain score reductions achieved with the 
sublingual administration of ketorolac and tramadol in children with acute abdominal pain, 
compared to the administration of a melt in the mouth powder of paracetamol. The a priori 
hypothesis was that ketorolac and tramadol could be more effective than paracetamol in 
inducing pain score reductions. 
 
METHODS 
 
This study was a multicentre randomised single-blind controlled trial that involved the 
emergency departments of three urban tertiary-level university teaching children’s 
hospitals in Italy. These were: the Institute for Maternal and Child Health IRCCS Burlo 
Garofolo, Trieste, the Pausilipon Hospital, AORN Santobono Pausilipon, Naples and the 
Gemelli Hospital, Catholic University of Sacred Hearth, Rome. Every year, these 
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emergency departments provide treatment to approximately 23,000, 80,000 and 
16,000 paediatric patients, respectively. The study was conducted between March 2015 
and June 2017.  
We enrolled children from four to 18 years of age who arrived at the emergency 
department complaining of moderate to severe acute abdominal pain. The children 
were eligible if they started complaining of abdominal pain started less than 48 hours 
before the emergency department evaluation and they self-reported their pain as at 
least six or more on an appropriate rating scale for their age. The exclusion criteria 
were a known allergy or sensitivity to non-steroidal anti-inflammatory drugs, opioids or 
paracetamol or the use of analgesic drugs in the eight hours before the medical 
evaluation. We also excluded children with a history of nephropathy, liver disease, 
metabolic or neurologic disease, thrombocytopenia or bleeding disorders or if the 
attending physician suspected during the  medical evaluation that their abdominal pain 
was due to faecal stasis or severe dehydration (11). 
After written, informed consent was obtained from a parent or legal guardian, the 
eligible children were randomly allocated to receive a maximum of 30mg of  ketorolac 
oral drops 0.5mg/kg sublingually, (ABC Farmaceutici SpA,  Ivrea, Italy) or a maximum of 
100mg of tramadol oral drops 2mg/kg sublingually (Grunenthal Italia Srl, Milan, Italy) 
or maximum of 1,000mg of a paracetamol 20mg/kg melt in the mouth powder (Angelini 
SpA, Ancona, Italy).  
A randomisation list, stratified by centre, with a fixed block size of 10, was generated 
using a computer-based method by an independent epidemiologist at the Clinical 
Epidemiology and Public Health Research Unit at IRCCS Burlo Garofolo. Allocation 
concealment was guaranteed by the use of sealed, opaque envelopes, which were 
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consecutively numbered and each contained the allocation group. The emergency 
department paediatrician opened the envelope marked with the lowest number 
available and assigned the patient to the corresponding group. The drug was 
administered by a nurse and the children and their families were blinded to which drug 
the child received.    
After the drug administration, the children were asked to report their pain every 30 
minutes.  
If no pain control was achieved at two hours, defined as a pain score of at least six point 
on the 0-10 scale, the patients were given a rescue analgesic, which was chosen by the 
emergency department paediatrician.  
One week after enrolment, the medical records of all children were reviewed to 
investigate if there was a missed or delayed diagnosis of acute appendicitis or other 
surgical condition.  
The study protocol had received approval from the Independent Bioethic Committee of 
the Institute for Maternal and Child Health IRCCS Burlo Garofolo. The trial was 
registered with ClinicalTrial.gov (NCT02465255) before the enrolment of the first 
participant. 
Children from four to seven years of age reported their pain using the Wong-Baker scale 
(12) and children aged eight or more reported their pain with the Numerical Rating 
Scale (13). For the statistical analyses, scores from both scales were transformed into a 
numerical value from zero for no pain to 10 for maximum pain, in accordance with 
previous studies, which demonstrated that scores reported using these two scales 
overlapped (14). 
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The primary study outcome was the child’s self-reported pain after 120 minutes.  
The secondary outcomes were pain scores at 30 and 60 minutes, the number of 
complicated cases of appendicitis and the number and types of adverse events. 
Statistical analyses 
This study was designed as a superiority trial. The data available in literature enabled 
us to estimate that ketorolac and tramadol would be more effective than paracetamol in 
providing pain relief (15).  
We hypothesised that 210 subjects – 70 for each group – would be needed to carry out 
the study. This was based on a difference in pain score of one point or more using 
ketorolac or tramadol, with a standard deviation of two alfa of 0.05 and beta of 0.20. 
Data were transferred to an electronic database and analysed by the Clinical 
Epidemiology and Public Health Research Unit of IRCCS Burlo Garofolo. The analyses 
were carried out according to the intention-to-treat principle. Continuous data were 
reported as medians and interquartile ranges (IQR) and as median differences and 95% 
confidence Intervals (95% CI). Categorical data were reported as numbers and 
percentages and as relative risks (RR) and 95% CIs. To evaluate the differences in pain 
scores between ketorolac versus paracetamol and tramadol versus paracetamol, we 
used the non-parametric Mann-Whitney U test, as a non-normal distribution of data was 
present.  Moreover, self-reported pain scores were dichotomised as no pain if the score 
was one to four out of ten and pain if it was five to 10 and the differences were analysed 
with the chi-square test or Fisher’s exact test, as appropriate. We chose a pain cut-off 
value of four because, in our practice, it is considered the limit for considerable pain. 
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Differences in secondary categorical outcomes were analysed with the chi-square test or 
Fisher’s exact test, when appropriate. All p values and estimates of treatment effects were based 
on separate comparisons, so no adjustments were made for multiple comparisons. Given that 
tramadol group presented with a higher frequency of appendicitis at diagnosis,  multivariate 
logistic regression analysis was carried out to adjust for this variable, the relationship between 
tramadol and paracetamol and the main study outcome, which was dichotomised. We 
considered a p value of < 0.05 statistically significant. All the analyses were carried out with 
SPSS software, version 21.0 (IBM Corp, Armonk, New York, USA). 
 
RESULTS 
  
We assessed 649 children for eligibility. Of these 158 decline to participate and 281 were 
excluded because they did not fulfil the study criteria. The main causes of exclusion were 
suspected constipation and a previous analgesic treatment. We enrolled 210 children: 70 were 
randomised to receive ketorolac, 70 to receive tramadol and 70 to receive paracetamol (Figure 
1). No violation of the randomisation occurred. Table 1 shows the main characteristics of the 
study population. There were no relevant differences between the three groups, expect for the 
number of cases of appendicitis, which was higher in the tramadol group (Table 1).  
Table 2 provides continuous data and Table 3 provides categorised data and they show the 
differences in pain scores between the three groups at the different times considered. No 
statistically significant differences between ketorolac versus paracetamol and tramadol versus 
paracetamol were found at any time, and, in particular, at  two hours, which was the main study 
outcome.  
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When we compared the children who took ketorolac and paracetamol, we found that tramadol 
had significantly more adverse events, mainly nausea and vomiting. None of the patients 
experienced an allergic reaction. No statistically significant difference was seen in the number of 
complicated cases of appendicitis (Table 4). 
The multivariate adjustments that took into account the imbalance between the tramadol and 
paracetamol groups in the number of appendicitis cases at diagnosis did not change the results. 
 
DISCUSSION 
 
This study showed that sublingual administration was a suitable way to provide prompt and 
effective analgesia for children with acute abdominal pain in emergency departments. 
While evidence is growing about the usefulness of the transmucosal routes of administration to 
provide analgesia in children with acute pain (6-8,16), no previous experience has focused on 
children with acute abdominal pain.  
Acute abdominal pain is a frequent cause of paediatric emergency department visits and, even 
though prompt pharmacological analgesia is strongly recommended, children with acute 
abdominal pain are still often undertreated (17-19). Paediatric studies focusing on analgesia in 
children with acute abdominal pain have only investigated the usefulness of major opioids such 
as morphine and oxycodone (4). Even though in clinical practice NSAIDs and paracetamol are 
frequently prescribed for children with acute abdominal pain (18,19), to the best of our 
knowledge this was the first trial to investigate the usefulness of an NSAID, paracetamol and an 
opioid such as tramadol, in this setting. Previous experiences with adult patients showed that 
intravenous tramadol and paracetamol were equally effective in reducing acute abdominal pain, 
without influencing examination findings (20,21). Moreover intravenous paracetamol, tramadol 
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and dexketoprofene were all effective in adults with acute pancreatitis (22) and intravenous 
ketorolac provided successful pain relief for adults with suspected biliary colic (23). We chose 
the sublingual route of administration and included tramadol in the study design because 
previous studies on analgesia for abdominal pain were mainly based on intravenous opiods and 
we wanted to provide the most efficacious, fast and non invasive route of administration in the 
study, including an opioid. Tramadol was preferred to fentanyl due to its longer duration of 
action. The maximum dose of 30mg of ketorolac was chosen in accordance with the maximum 
intravenous dose. It is notable that a single dose of ketorolac is considered safe even if a patient 
may undergo surgery (24,25). 
In our series ketorolac and tramadol were not superior to paracetamol in managing pain, but 
children, who took tramadol experienced significantly more adverse events. The data were 
similar to that of a previous study, which investigated sublingual ketorolac and tramadol in 
children with acute bone pain (7). 
Our study did not focus on the influence of the analgesic treatment on the diagnostic accuracy of 
a surgical abdominal condition, but in our series the percentage of cases with complicated 
appendicitis was similar to that reported in children by previous studies (26) and it did not 
seem to be influenced by the drug regimen.  
Sublingual treatment could be more acceptable to children than an intravenous route (16) and a 
first-line transmucosal treatment could be more convenient for an emergency physician, 
facilitating prompt and widespread analgesia. 
This study had some limitations. First of all, it was not double blinded, but this was not possible 
because of the different formulations of paracetamol. The route of administration of the drugs 
cannot be straightforwardly defined as sublingual, in the true sense of the word, since from a 
chemical perspective the ketorolac and tramadol formulations we used were made for oral 
absorption and they were not optimised for transmucosal absorption. Furthermore, we could 
not exclude that the drug effect was due, in part, to the swallowed amount of the drug. Melt in 
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the mouth paracetamol powder is not available in all countries and this could limit the 
generalisation of our findings. The trial was carried out before the warning from the American 
Food and Drug Administration that tramadol should not be used in patients who are younger 
than 12 years of age (12). Tramadol was still on label for children in many countries at the time 
of our study, but it had already been reported and was well known that its use should be 
avoided in children at risk of respiratory depression, such as a history of sleep apnoea, those 
undergoing a tonsillectomy and obese patients (10). We did not investigate the palatability of 
the drugs, but sublingual ketorolac and tramadol were very well accepted in a previous study 
(7). Finally, we found a higher frequency of cases of appendicitis in the tramadol group. This 
imbalance cannot be attributed to the lack of blindness. An independent epidemiologist carried 
out the randomisation and the list was adequately concealed using opaque sealed envelopes. 
Therefore, we believe that the groups were casually imbalanced. However, the multivariate 
adjustment did not change the results. 
The strengths of the study were its multicentre design, the considerable number of patients 
enrolled and the novel description of the  sublingual administration of commonly used 
medication in children with acute abdominal pain. 
 
CONCLUSION 
 
This multicentre randomised controlled trial was the first to investigated the sublingual 
administration of ketorolac and tramadol in children with acute abdominal pain in emergency 
departments. Both drugs were effective at relieving pain in these children. Our findings suggest 
that placing these drugs under the tongue may be an alternative route of administration in 
children presenting with acute abdominal pain in emergency departments. 
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Table 1. Patient’s characteristics 
 
Patient’s characteristics ketorolac (n=70) tramadol (n=70) paracetamol (n=70) 
Age in years, median 
(IQR) 
12.0 (9.0-14.0) 12.0 (9.0-14.0) 12.0 (9.0-14.3) 
Male sex, n (%) 21 (30.0%) 34 (48.6%) 32 (45.7%) 
Pain duration before 
emergency department 
evaluation, hours, 
median (IQR) 
12 (5.8-24) 10 (5.0-28.5) 13.5 (7.5-30) 
Pain intensity at 
emergency department 
evaluation, median 
(IQR) 
7.0 (6.8-8.0) 8.0 (7.0-8.0) 8.0 (7.0-8.0) 
Diagnosis at the 
medical evaluation: 
   
appendicitis 5 (7.1%) 15 (21.4%) 8 (11.4%) 
gynecological causes 9 (12.9%) 4 (5.7%) 10 (14.3%) 
urological causes 3 (4.3%) 3 (4.3%) 3 (4.3%) 
viral infections 32 (45.7%) 24 (34.3%) 29 (41.4%) 
abdominal colic pain 16 (22.9%) 20 (28.6%) 15 (21.4%) 
functional pain  0 (0.0%) 2 (2.9%) 2 (2.9%) 
other 5 (7.1%) 2 (2.9%) 3 (4.3%) 
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Table 2. Self-reported pain after 120 (main study outcome), 30 and 60 minutes after drugs 
administration, continuous variables, comparison between ketorolac and tramadol versus 
paracetamol 
 
 ketorolac 
(n=70) 
tramadol 
(n=70) 
paracetamol 
(n=70) 
ketorolac vs 
paracetamol, 
median 
difference 
(95% CI) 
p tramadol vs 
paracetamol, 
median 
difference 
(95% CI) 
p 
Pain 
score at 
120 min, 
median 
(IQR) 
2.0 (0.0-
4.3) 
3.0 (1.0-
5.0) 
3.0 (0.8-5.0) -1.0 (-2.0-0.0) 0.15 0.0 (-1.0-1.0) 0.97 
Pain 
score at 
30 min, 
median 
(IQR) 
5.0 (4.0-
7.0) 
6.0 (4.0-
7.0) 
6.0 (4.0-6.0) 0.0 (-1.0-0.0) 0.43 0.0 (0.0-1.0) 0.42 
Pain 
score at 
60 min, 
median 
(IQR) 
3.5 (2.0-
6.0) 
4.0 (2.8-
6.0) 
4 (2.0-6.0) 0.0 (-1.0-1.0) 0.61 0.0 (0.0-1.0) 0.32 
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Table 3. Self-reported pain after 120 (main study outcome), 30 and 60 minutes after drugs 
administration, categorical variables, comparison between ketorolac and tramadol versus 
paracetamol 
 
 ketorolac 
(n=70) 
tramadol 
(n=70) 
paracetamol 
(n=70) 
ketorolac vs 
paracetamol, 
relative risk 
(95% CI) 
p tramadol vs 
paracetamol, 
relative risk 
(95% CI) 
p 
No or 
mild 
pain 
(score  
4) at 120 
min, n 
(%) 
53 (75.7%) 49 (70.0%) 48 (68.6%) 1.20 (0.81-
1.80) 
0.35 1.02 (0.82-
1.27) 
0.86 
No or 
mild 
pain 
(score  
4) at 30 
min, n 
(%) 
28 (40.0%) 21 (30.0%) 22 (31.4%) 1.27 (0.81-
2.00) 
0.29 0.96 (0.58-
1.57) 
0.86 
No or 
mild 
pain 
(score  
4) at 60 
min  
44 (62.9%) 37 (52.9%) 40 (57.1%) 1.10 (0.84-
1.44) 
0.49 0.93 (0.69-
1.25) 
0.61 
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Table 4. Complicated appendicitis and adverse events, comparison between ketorolac and 
tramadol versus paracetamol  
 
 ketorolac 
(n=70) 
tramadol 
(n=70) 
paracetamol 
(n=70) 
ketorolac vs 
paracetamol, 
relative risk 
(95% CI) 
p tramadol vs 
paracetamol, 
relative risk 
(95% CI) 
p 
Complicated 
appendicitis 
0 3 (4.3%) 1 (1.4%) - 1.00* 3.00 (0.31-
28.14) 
0.62* 
Adverse 
events, n (%) 
2 (2.9%) 18 
(25.7%) 
2 (2.9%) 1.00 (0.15-
6.90) 
1.00* 9.00 (2.17-
37.34) 
<0.001 
Types of 
adverse 
events 
       
Nausea 0 8 1     
Vomit 1 10 1     
Dizziness 0 3 0     
Epigastric 
pain 
1 0 0     
 
* Fisher exact test 
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